Madeline Bartsch
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Madeline Bartsch has a total of 30 co-authors. Here are the top co-authors by number of shared publications:
- Andreas Hahn
Institute of Food Science and Human Nutrition, Leibniz University Hannover, 30167 Hannover, Germany
5 shared publications - Mattea Müller
Institute of Food and One Health, Leibniz University Hannover
4 shared publications - Mariana Romanenko
D.F. Chebotarev Institute of Gerontology
3 shared publications Marius Vital
Institute for Medical Microbiology and Hospital Epidemiology, Hannover Medical School, Hannover, Germany
3 shared publicationsAndreas Hahn
Institute of Food and One Health, Leibniz University Hannover, 30167 Hannover, Germany
2 shared publications- Anna Havalko
D.F. Chebotarev Institute of Gerontology
2 shared publications
Latest Publications
- Top Cited PapersOpen Access
- 20 January 2026
- Published by Springer Nature in Nutrition & Metabolism
- Vol. 23 (1)
Gut microbiome mediates the association between dietary quality and metabolic risk in a heterogeneous adult population
Background: Diet is a determinant of metabolic health, partly through its effects on the gut microbiome, which influences nutrient metabolism, inflammation, and energy balance. We investigated the mediating role of gut microbiome features in the association between dietary quality and metabolic risk. Methods: In this cross-sectional study, we included 269 adults aged 25–76 years with heterogeneous metabolic profiles, BMI ranging from 17.5 to 47.6 kg/m², and fasting glucose levels between 5.6 and 6.9 mmol/L. Dietary quality was assessed using the Healthy Eating Index (HEI-MON), the Planetary Health Diet Index (PHEI-MON), and the alternate Mediterranean Diet Score (aMED), derived from food-frequency questionnaires and three-day food records. Metabolic risk was quantified using a continuous metabolic syndrome score (cMetS) incorporating waist circumference, mean arterial pressure, HDL cholesterol, triglycerides, and fasting glucose. Microbiome composition (16 S rRNA gene sequencing) and predicted SCFA pathways were analyzed using adjusted multiple linear regression, PERMANOVA, and differential abundance analysis. Mediation analyses examined microbial features as potential mediators of the association between diet and metabolic risk. Results: Higher HEI-MON, PHEI-MON, and aMED were associated with lower cMetS ( q < 0.01). Christensenellaceae R7 group and Ruminococcaceae NK4A214 group were enriched with higher dietary quality and lower cMetS ( q < 0.1), whereas Lachnoclostridium were associated with lower diet quality and higher cMetS ( q < 0.1). The Enterotype Dysbiosis Score (EDS) correlated inversely with dietary quality (PHEI-MON q = 0.04) and positively with cMetS ( q = 0.04). Butyrate-synthesis pathways were more abundant in individuals with higher dietary quality ( q < 0.05) and inversely associated with cMetS ( q < 0.05). Mediation analysis indicated that the Ruminococcaceae NK4A214 group , the Christensenellaceae R7 group , and Lachnoclostridium accounted for up to 16% of the association between diet and metabolic risk. Conclusion: Better dietary quality is associated with lower metabolic risk and positive gut microbiome signatures across taxonomic, functional, and stability-related aspects. Certain taxa statistically mediated these associations, highlighting gut microbiome features that may contribute to observed links between dietary patterns and metabolic health. Graphical
- 20 January 2026
- Published by Springer Nature in Nutrition & Metabolism
- Vol. 23 (1)
Top Cited PapersOpen AccessGut microbiome mediates the association between dietary quality and metabolic risk in a heterogeneous adult population
Background: Diet is a determinant of metabolic health, partly through its effects on the gut microbiome, which influences nutrient metabolism, inflammation, and energy balance. We investigated the mediating role of gut microbiome features in the association between dietary quality and metabolic risk. Methods: In this cross-sectional study, we included 269 adults aged 25–76 years with heterogeneous metabolic profiles, BMI ranging from 17.5 to 47.6 kg/m², and fasting glucose levels between 5.6 and 6.9 mmol/L. Dietary quality was assessed using the Healthy Eating Index (HEI-MON), the Planetary Health Diet Index (PHEI-MON), and the alternate Mediterranean Diet Score (aMED), derived from food-frequency questionnaires and three-day food records. Metabolic risk was quantified using a continuous metabolic syndrome score (cMetS) incorporating waist circumference, mean arterial pressure, HDL cholesterol, triglycerides, and fasting glucose. Microbiome composition (16 S rRNA gene sequencing) and predicted SCFA pathways were analyzed using adjusted multiple linear regression, PERMANOVA, and differential abundance analysis. Mediation analyses examined microbial features as potential mediators of the association between diet and metabolic risk. Results: Higher HEI-MON, PHEI-MON, and aMED were associated with lower cMetS ( q < 0.01). Christensenellaceae R7 group and Ruminococcaceae NK4A214 group were enriched with higher dietary quality and lower cMetS ( q < 0.1), whereas Lachnoclostridium were associated with lower diet quality and higher cMetS ( q < 0.1). The Enterotype Dysbiosis Score (EDS) correlated inversely with dietary quality (PHEI-MON q = 0.04) and positively with cMetS ( q = 0.04). Butyrate-synthesis pathways were more abundant in individuals with higher dietary quality ( q < 0.05) and inversely associated with cMetS ( q < 0.05). Mediation analysis indicated that the Ruminococcaceae NK4A214 group , the Christensenellaceae R7 group , and Lachnoclostridium accounted for up to 16% of the association between diet and metabolic risk. Conclusion: Better dietary quality is associated with lower metabolic risk and positive gut microbiome signatures across taxonomic, functional, and stability-related aspects. Certain taxa statistically mediated these associations, highlighting gut microbiome features that may contribute to observed links between dietary patterns and metabolic health. Graphical
- 17 December 2025
- Published by State Institution - D. F. Chebotarev Institute of Gerontology NAMS of Ukraine in Problems of ageing and longevity (Ukraine)
- Vol. 30 (4) , 88
Circadian desynchronization and its impact on the gut microbiome: a literature revie
Chronobiological studies of the human gut microbiome mainly focus on the effects of circadian desynchronization factors. A reduction in sleep duration, quality, or efficiency is associated with decreased microbiota diversity and changes in its composition, particularly with a decline in short-chain fatty acid–producing bacteria. Short-term models of total sleep deprivation show the most pronounced taxonomic and functional shifts in the microbiome, along with increased intestinal permeability and signs of subclinical inflammation. The effects of such desynchronizers as shift work or irregular eating patterns are less clear: most studies do not report significant changes in microbiota diversity or composition, although the abundance of certain taxa has been associated with the timing of sleep and meals. Short-term interventional studies often yield inconsistent results, suggesting that the human microbiome is more sensitive to long-term lifestyle changes or to the combined impact of multiple stress factors. Overall, stable sleep and eating schedules are important for maintaining microbiome diversity and a composition associated with favourable metabolic outcomes.
- 17 December 2025
- Published by State Institution - D. F. Chebotarev Institute of Gerontology NAMS of Ukraine in Problems of ageing and longevity (Ukraine)
- Vol. 30 (4) , 88
Circadian desynchronization and its impact on the gut microbiome: a literature revie
Chronobiological studies of the human gut microbiome mainly focus on the effects of circadian desynchronization factors. A reduction in sleep duration, quality, or efficiency is associated with decreased microbiota diversity and changes in its composition, particularly with a decline in short-chain fatty acid–producing bacteria. Short-term models of total sleep deprivation show the most pronounced taxonomic and functional shifts in the microbiome, along with increased intestinal permeability and signs of subclinical inflammation. The effects of such desynchronizers as shift work or irregular eating patterns are less clear: most studies do not report significant changes in microbiota diversity or composition, although the abundance of certain taxa has been associated with the timing of sleep and meals. Short-term interventional studies often yield inconsistent results, suggesting that the human microbiome is more sensitive to long-term lifestyle changes or to the combined impact of multiple stress factors. Overall, stable sleep and eating schedules are important for maintaining microbiome diversity and a composition associated with favourable metabolic outcomes.
- Top Cited PapersOpen Access
- 4 September 2025
- Published by Elsevier in The Journal of Nutrition
- Vol. 155 (11) , 3809-3822
Microbiota-Dependent Fiber Responses: A Proof-of-Concept Study on Short-Chain Fatty Acid Production in Prevotella- and Bacteroides-Dominated Healthy Individuals
- 4 September 2025
- Published by Elsevier in The Journal of Nutrition
- Vol. 155 (11) , 3809-3822
Top Cited PapersOpen AccessMicrobiota-Dependent Fiber Responses: A Proof-of-Concept Study on Short-Chain Fatty Acid Production in Prevotella- and Bacteroides-Dominated Healthy Individuals
- Open Access
- 1 September 2025
- Published by State Institution - D. F. Chebotarev Institute of Gerontology NAMS of Ukraine
- Vol. 30 (3) , 129-146
Сircadian regulation and the gut microbiome: mechanisms of interaction
Current evidence demonstrates that the gut microbiome has its own rhythmicity and plays an important role in regulating the functional rhythms of the gastrointestinal tract as well as in aligning peripheral circadian clocks with sleep–wake and light–dark cycles. Preclinical studies indicate that the loss of microbiota rhythmicity may contribute to the development of metabolic disorders. Factors such as genetic mutations in the circadian clock, jet lag, total sleep deprivation and high-fat diets are associated with reduced microbiota diversity, decreased abundance of short-chain fatty acid–producing bacteria, partial loss of microbial rhythmicity, and alterations in functional activity. Notably, in some cases functional activity appears to be more sensitive to circadian desynchronization than composition or diversity. This opens prospects for new diagnostic and therapeutic strategies, however, it remains unclear to what extent preclinical findings can be extrapolated to clinical practice. Further controlled clinical studies are needed to elucidate the mechanisms underlying the interactions between the microbiome, circadian rhythms, and human metabolic health.
- 1 September 2025
- Published by State Institution - D. F. Chebotarev Institute of Gerontology NAMS of Ukraine
- Vol. 30 (3) , 129-146
Open AccessСircadian regulation and the gut microbiome: mechanisms of interaction
Current evidence demonstrates that the gut microbiome has its own rhythmicity and plays an important role in regulating the functional rhythms of the gastrointestinal tract as well as in aligning peripheral circadian clocks with sleep–wake and light–dark cycles. Preclinical studies indicate that the loss of microbiota rhythmicity may contribute to the development of metabolic disorders. Factors such as genetic mutations in the circadian clock, jet lag, total sleep deprivation and high-fat diets are associated with reduced microbiota diversity, decreased abundance of short-chain fatty acid–producing bacteria, partial loss of microbial rhythmicity, and alterations in functional activity. Notably, in some cases functional activity appears to be more sensitive to circadian desynchronization than composition or diversity. This opens prospects for new diagnostic and therapeutic strategies, however, it remains unclear to what extent preclinical findings can be extrapolated to clinical practice. Further controlled clinical studies are needed to elucidate the mechanisms underlying the interactions between the microbiome, circadian rhythms, and human metabolic health.
- Open Access
- 31 July 2025
- Published by Taylor & Francis in Chronobiology International
- p. 1-21
Gut microbiota and circadian disruption in humans: Is there a rationale for metabolic disorders?
Circadian disruption, arising from behaviors such as shift work and sleep deprivation, is increasingly prevalent and associated with metabolic disorders, including obesity, type 2 diabetes, and cardiovascular disease. The gut microbiome plays a crucial role in metabolic homeostasis by producing metabolites - such as short-chain fatty acids, secondary bile acids, and microbial-associated molecular patterns - that influence nutrient absorption, immune responses, and host metabolism in alignment with circadian rhythms. This review explores how circadian disruptors influence the human gut microbiome, focusing on changes in microbial composition, diversity, and functionality, and their implications for metabolic health. Preclinical studies demonstrate that circadian disruptions alter microbial composition, reduce rhythmicity, and impair functionality, contributing to metabolic disorders. However, human studies often report inconsistent findings, with microbial functionality appearing more sensitive to disruptions than composition. Eating patterns affect both the gut microbiome and circadian alignment; their optimization could realign microbial and host rhythms to promote metabolic homeostasis. Future research should focus on longitudinal and interventional studies using advanced methodologies, such as real-time intestinal gas measurements, to capture dynamic microbial activity in humans. Understanding microbial responses to circadian disruptors could inform therapeutic strategies targeting host-microbe interactions to improve metabolic health.
- 31 July 2025
- Published by Taylor & Francis in Chronobiology International
- p. 1-21
Open AccessGut microbiota and circadian disruption in humans: Is there a rationale for metabolic disorders?
Circadian disruption, arising from behaviors such as shift work and sleep deprivation, is increasingly prevalent and associated with metabolic disorders, including obesity, type 2 diabetes, and cardiovascular disease. The gut microbiome plays a crucial role in metabolic homeostasis by producing metabolites - such as short-chain fatty acids, secondary bile acids, and microbial-associated molecular patterns - that influence nutrient absorption, immune responses, and host metabolism in alignment with circadian rhythms. This review explores how circadian disruptors influence the human gut microbiome, focusing on changes in microbial composition, diversity, and functionality, and their implications for metabolic health. Preclinical studies demonstrate that circadian disruptions alter microbial composition, reduce rhythmicity, and impair functionality, contributing to metabolic disorders. However, human studies often report inconsistent findings, with microbial functionality appearing more sensitive to disruptions than composition. Eating patterns affect both the gut microbiome and circadian alignment; their optimization could realign microbial and host rhythms to promote metabolic homeostasis. Future research should focus on longitudinal and interventional studies using advanced methodologies, such as real-time intestinal gas measurements, to capture dynamic microbial activity in humans. Understanding microbial responses to circadian disruptors could inform therapeutic strategies targeting host-microbe interactions to improve metabolic health.
- Open Access
- 1 July 2025
- Published by SAGE Publications in Nutrition and Healthy Aging
- Vol. 10
Exploring the relationship between dietary indices, gut microbiota, and health status in healthy, older individuals
Background: With increasing life expectancy, dietary choices are crucial for healthy aging. Objective: This study investigates associations between two dietary indices, the energy-adjusted Dietary Inflammatory Index (E-DII) and the healthful Plant-based Diet Index (hPDI), and biomarkers related to metabolic health and micronutrient status, focusing on the mediating role of gut microbiota. Methods: We conducted a secondary, exploratory analysis of baseline data from 129 community-based participants aged ≥70 years (median age: 75 years). Dietary indices were calculated from 3-day food protocols, and biomarkers were measured in blood samples. Cognitive and physical function were assessed using validated questionnaires, body composition was determined via bioimpedance, and fecal gut microbiota composition through 16S rRNA gene sequencing. Statistical analyses included multiple linear regression models, Permutational Multivariate Analysis of Variance, and mediation analysis. Results: We found no significant associations between the indices and gut microbiota diversity. However, red blood cell (RBC) folate and serum uric acid were significantly associated with E-DII (stand. β = −0.32 and 0.23, respectively, p < 0.01 and 0.01) and contributed to microbiota composition variance (R 2 = 0.01, Q = 0.21). Specific genera correlated with serum uric acid ( Oscillibacter : coefficient = −0.01, Q = 0.24, Gemmiger : coefficient = −0.02, Q = 0.23) and RBC folate ( Bacteroides : coefficient = 0.03, Q = 0.22), independent of dietary patterns. Conclusions: This study suggests that gut microbiota composition does not mediate the associations between a healthy plant-based or anti-inflammatory diet and metabolic health markers in a healthy, older population. However, microbial genera were associated with uric acid and folate concentrations independent of the investigated dietary patterns, indicating potential roles in folate and uric acid metabolism.
- 1 July 2025
- Published by SAGE Publications in Nutrition and Healthy Aging
- Vol. 10
Open AccessExploring the relationship between dietary indices, gut microbiota, and health status in healthy, older individuals
Background: With increasing life expectancy, dietary choices are crucial for healthy aging. Objective: This study investigates associations between two dietary indices, the energy-adjusted Dietary Inflammatory Index (E-DII) and the healthful Plant-based Diet Index (hPDI), and biomarkers related to metabolic health and micronutrient status, focusing on the mediating role of gut microbiota. Methods: We conducted a secondary, exploratory analysis of baseline data from 129 community-based participants aged ≥70 years (median age: 75 years). Dietary indices were calculated from 3-day food protocols, and biomarkers were measured in blood samples. Cognitive and physical function were assessed using validated questionnaires, body composition was determined via bioimpedance, and fecal gut microbiota composition through 16S rRNA gene sequencing. Statistical analyses included multiple linear regression models, Permutational Multivariate Analysis of Variance, and mediation analysis. Results: We found no significant associations between the indices and gut microbiota diversity. However, red blood cell (RBC) folate and serum uric acid were significantly associated with E-DII (stand. β = −0.32 and 0.23, respectively, p < 0.01 and 0.01) and contributed to microbiota composition variance (R 2 = 0.01, Q = 0.21). Specific genera correlated with serum uric acid ( Oscillibacter : coefficient = −0.01, Q = 0.24, Gemmiger : coefficient = −0.02, Q = 0.23) and RBC folate ( Bacteroides : coefficient = 0.03, Q = 0.22), independent of dietary patterns. Conclusions: This study suggests that gut microbiota composition does not mediate the associations between a healthy plant-based or anti-inflammatory diet and metabolic health markers in a healthy, older population. However, microbial genera were associated with uric acid and folate concentrations independent of the investigated dietary patterns, indicating potential roles in folate and uric acid metabolism.
- Open Access
- 23 March 2025
- Published by MDPI AG in Marine Drugs
- Vol. 23 (4) , 139
Calanus Oil and Lifestyle Interventions Improve Glucose Homeostasis in Obese Subjects with Insulin Resistance
Obesity increases the risk for insulin resistance (IR) and type-2 diabetes. Lifestyle interventions (LI) and dietary supplementation can help mitigate IR. We investigated the effect of calanus oil (CO) supplementation, combined with LI, on glucose homeostasis in obese subjects. CO, a novel marine oil, contains omega-3 fatty acid wax esters as well as plant sterols and astaxanthin. In the double-blind, randomized, placebo-controlled 12-week intervention study, 266 subjects with distinct IR phenotypes were assigned to four groups: 2 g CO/day, 4 g CO/day, 2 g CO/day + LI, and placebo. The effect of CO on HOMA index reduction was influenced by the initial (t0) squared HOMA index (interaction p = 0.011). A post hoc test showed significant improvement with 2 g CO/day + LI (estimated marginal means [EMM] 95% confidence interval [CI]: −0.19 [−0.80–0.41], p = 0.021). Secondary analysis revealed that 4 g CO/day had significant effects in subjects with mild IR (HOMA index 2.5–5.0) (EMM [95% CI]: −0.76 [−1.53–0.03], p = 0.043). CO supplementation improved glucose homeostasis, with effects varying by dose, combination with LI, and IR phenotype.
- 23 March 2025
- Published by MDPI AG in Marine Drugs
- Vol. 23 (4) , 139
Open AccessCalanus Oil and Lifestyle Interventions Improve Glucose Homeostasis in Obese Subjects with Insulin Resistance
Obesity increases the risk for insulin resistance (IR) and type-2 diabetes. Lifestyle interventions (LI) and dietary supplementation can help mitigate IR. We investigated the effect of calanus oil (CO) supplementation, combined with LI, on glucose homeostasis in obese subjects. CO, a novel marine oil, contains omega-3 fatty acid wax esters as well as plant sterols and astaxanthin. In the double-blind, randomized, placebo-controlled 12-week intervention study, 266 subjects with distinct IR phenotypes were assigned to four groups: 2 g CO/day, 4 g CO/day, 2 g CO/day + LI, and placebo. The effect of CO on HOMA index reduction was influenced by the initial (t0) squared HOMA index (interaction p = 0.011). A post hoc test showed significant improvement with 2 g CO/day + LI (estimated marginal means [EMM] 95% confidence interval [CI]: −0.19 [−0.80–0.41], p = 0.021). Secondary analysis revealed that 4 g CO/day had significant effects in subjects with mild IR (HOMA index 2.5–5.0) (EMM [95% CI]: −0.76 [−1.53–0.03], p = 0.043). CO supplementation improved glucose homeostasis, with effects varying by dose, combination with LI, and IR phenotype.